These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30923876)

  • 1. Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients.
    Blumfield E; Swenson DW; Iyer RS; Stanescu AL
    Pediatr Radiol; 2019 Apr; 49(4):448-457. PubMed ID: 30923876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
    Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
    Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and Safety of Gadolinium Based Contrast Agents in Pediatric MR Imaging.
    Holowka S; Shroff M; Chavhan GB
    Indian J Pediatr; 2019 Oct; 86(10):961-966. PubMed ID: 30796704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and chemical forms of gadolinium in the brain: a review.
    Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
    Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
    Ichikawa S; Omiya Y; Onishi H; Motosugi U
    J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.
    Zhang Y; Cao Y; Shih GL; Hecht EM; Prince MR
    Radiology; 2017 Feb; 282(2):516-525. PubMed ID: 27513848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical aspects of MRI signal change quantification after gadolinium-based contrast agents' administration.
    Ramalho J; Ramalho M; AlObaidy M; Semelka RC
    Magn Reson Imaging; 2016 Dec; 34(10):1355-1358. PubMed ID: 27693606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
    Young JR; Qiao J; Orosz I; Salamon N; Franke MA; Kim HJ; Pope WB
    Eur Radiol; 2018 Nov; 28(11):4882-4889. PubMed ID: 29744642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.
    Layne KA; Dargan PI; Archer JRH; Wood DM
    Br J Clin Pharmacol; 2018 Nov; 84(11):2522-2534. PubMed ID: 30032482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
    Hu HH; Pokorney A; Towbin RB; Miller JH
    Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
    Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
    Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.
    Olchowy C; Cebulski K; Łasecki M; Chaber R; Olchowy A; Kałwak K; Zaleska-Dorobisz U
    PLoS One; 2017; 12(2):e0171704. PubMed ID: 28187173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
    McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
    Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
    Kasper E; Schemuth HP; Horry S; Kinner S
    Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain gadolinium deposition after administration of gadolinium-based contrast agents.
    Kanda T; Oba H; Toyoda K; Kitajima K; Furui S
    Jpn J Radiol; 2016 Jan; 34(1):3-9. PubMed ID: 26608061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium deposition in the brain.
    Kanda T; Nakai Y; Oba H; Toyoda K; Kitajima K; Furui S
    Magn Reson Imaging; 2016 Dec; 34(10):1346-1350. PubMed ID: 27613998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of IV-gadolinium Leakage from the Cortical Veins into the CSF Using MR Fingerprinting.
    Naganawa S; Nakane T; Kawai H; Taoka T; Kawaguchi H; Maruyama K; Murata K; Körzdörfer G; Pfeuffer J; Nittka M; Sone M
    Magn Reson Med Sci; 2020 May; 19(2):141-146. PubMed ID: 31217367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
    Rossi Espagnet MC; Bernardi B; Pasquini L; Figà-Talamanca L; Tomà P; Napolitano A
    Pediatr Radiol; 2017 Sep; 47(10):1345-1352. PubMed ID: 28526896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to Reduce the Use of Gadolinium-Based Contrast Agents for Abdominal MRI in Children.
    Anderson MA; Harrington SG; Kozak BM; Gee MS
    AJR Am J Roentgenol; 2020 May; 214(5):1054-1064. PubMed ID: 32097030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.